Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop

被引:2
作者
Axelrad, Jordan E. [1 ]
Cross, Raymond K. [2 ]
机构
[1] NYU, Grossman Sch Med, Dept Med, Div Gastroenterol, New York, NY 10012 USA
[2] Univ Maryland, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Baltimore, MD USA
关键词
colorectal neoplasia; dysplasia; colorectal cancer; inflammatory bowel disease; ulcerative colitis; Crohn's disease; colonoscopy; EVIDENCE-BASED CONSENSUS; ULCERATIVE-COLITIS; AMERICAN-COLLEGE; CANCER-RISK; DYSPLASIA; GUIDELINES; MANAGEMENT; ENDOSCOPY; UPDATE; METAANALYSIS;
D O I
10.14309/ajg.0000000000002168
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with chronic ulcerative and Crohn's colitis are at increased risk for colorectal neoplasia(CRN [dysplasia and cancer]) compared to the general population. Risk factors for CRN include extent of colitis, cumulative inflammatory burden, family history of colorectal cancer, and primary sclerosing cholangitis. Best practices to prevent CRN include control of colonic inflammation, high quality surveillance colonoscopy with or without enhanced imaging techniques, resection of visible dysplasia if possible, and colectomy in patients with unresectable dysplasia, invisible multifocal low grade dysplasia, or invisible high grade dysplasia. Cessation of dysplasia surveillance is individualized and should involve shared decision making based on factors including but not limited to chronologic age, frailty, co-morbid conditions, life expectancy, results of prior surveillance exams, and risk factors for CRN.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 50 条
[31]   Inflammatory bowel disease associated neoplasia: A surgeon's perspective [J].
Althumairi, Azah A. ;
Lazarev, Mark G. ;
Gearhart, Susan L. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (03) :961-973
[32]   Inflammatory Bowel Disease Cancer Risk, Detection and Surveillance [J].
Rogler, Gerhard .
DIGESTIVE DISEASES, 2012, 30 :48-54
[33]   Endoscopic Surveillance in Inflammatory Bowel Disease [J].
Goetz, Martin .
VISCERAL MEDICINE, 2018, 34 (01) :66-71
[34]   Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease [J].
Lopez, Anthony ;
Collet-Fenetrier, Benjamin ;
Belle, Arthur ;
Peyrin-Biroulet, Laurent .
JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (06) :383-391
[35]   Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease [J].
Yashiro, Masakazu .
DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (08) :2251-2263
[36]   Colorectal adenomas in patients presenting with inflammatory bowel disease [J].
Loffeld, R. J. L. F. .
NETHERLANDS JOURNAL OF MEDICINE, 2009, 67 (01) :21-24
[37]   Colorectal Cancer in Inflammatory Bowel Disease [J].
Stidham, Ryan W. ;
Higgins, Peter D. R. .
CLINICS IN COLON AND RECTAL SURGERY, 2018, 31 (03) :168-178
[38]   Surveillance for colorectal cancer in patients with inflammatory bowel disease [J].
Hurley, Joanna J. ;
Turner, Jeff ;
Berrill, James ;
Swift, Gillian ;
Dolwani, Sunil ;
Green, John .
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (10) :562-567
[39]   Colorectal Cancer in Inflammatory Bowel Disease [J].
Nebbia, Martina ;
Yassin, Nuha A. ;
Spinelli, Antonino .
CLINICS IN COLON AND RECTAL SURGERY, 2020, 33 (05) :305-317
[40]   Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management [J].
Sato, Yoshihiro ;
Tsujinaka, Shingo ;
Miura, Tomoya ;
Kitamura, Yoh ;
Suzuki, Hideyuki ;
Shibata, Chikashi .
CANCERS, 2023, 15 (16)